Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics.
about
Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patientsTernary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell linesOxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancerA phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients.The inverse starving test is not a suitable provocation test for Gilbert's syndromePhase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group studyIrinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.Oxaliplatin: a review of evolving concepts.Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.Metastatic colorectal cancer: systemic treatment in the new millennium.Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I-II trial.Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma.Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumoursExacerbation of oxaliplatin neurosensory toxicity following surgery.Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
P2860
Q28346039-BD05783C-0687-4970-B6A0-FA1B1F571784Q28350941-AD16337B-1106-4B8F-8758-6DEC00E64976Q28364999-74CF7E72-AD96-4B48-8D09-34720F4C8FC2Q33357544-027B2ABB-50B4-497E-8131-2E791225ED2AQ33360903-F09392D7-7E33-4381-907A-CA1213D38F5CQ33964850-DB48D9B5-2C49-4986-9C15-742BA457AFC0Q34504536-3B431782-A24D-4226-83BB-9419695D1784Q34569008-1FD2AEB0-0F80-40F8-A2BE-54884E05F359Q35008045-CA0FC022-8602-4B94-AE51-5914EA3FC34FQ35148795-814224AF-DCD6-424F-A40F-DB71ED6964CAQ36614907-615C4ED9-EDCD-4B88-9188-1F732600C39BQ36623730-CAFD9D36-3821-424A-93BF-DBEE833A874BQ36648316-2E5B97B9-A135-4568-9F9F-D18798AA393EQ44104089-BC6D2A91-7D0F-412C-AD8D-A46C44B8A0AFQ52362144-C2687526-2672-4041-91C4-23C956F167F5
P2860
Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Combination of oxaliplatin plu ...... studies with pharmacokinetics.
@ast
Combination of oxaliplatin plu ...... studies with pharmacokinetics.
@en
Combination of oxaliplatin plu ...... studies with pharmacokinetics.
@nl
type
label
Combination of oxaliplatin plu ...... studies with pharmacokinetics.
@ast
Combination of oxaliplatin plu ...... studies with pharmacokinetics.
@en
Combination of oxaliplatin plu ...... studies with pharmacokinetics.
@nl
prefLabel
Combination of oxaliplatin plu ...... studies with pharmacokinetics.
@ast
Combination of oxaliplatin plu ...... studies with pharmacokinetics.
@en
Combination of oxaliplatin plu ...... studies with pharmacokinetics.
@nl
P2093
P1476
Combination of oxaliplatin plu ...... studies with pharmacokinetics.
@en
P2093
A Besmaine
D Méry-Mignard
E Cvitkovic
E Wasserman
F Goldwasser
G Dupont-André
J L Misset
M Mahjoubi
P304
P356
10.1200/JCO.1999.17.6.1751
P407
P577
1999-06-01T00:00:00Z